⌘K

Login Start Free

Home/Filings/4/0000810084-09-000021

4//SEC Filing

Makar Ralph 4

Accession 0000810084-09-000021

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 8:56 PM ET

Size

8.4 KB

Accession

0000810084-09-000021

Insider Transaction Report

Form 4

Period: 2009-10-01

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

CEO/President

Transactions

Exercise/Conversion
Restricted Stock Unit
2009-10-01−33,333→ 357,601 total
From: 2009-10-01→ BJCT Common Stock (33,333 underlying)
Exercise/Conversion
BJCT Common Stock
2009-10-01+33,333→ 344,034 total

Holdings

BJCT Common Stock
(indirect: By 401(k))
86,916

Footnotes (5)

[F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
[F2]Includes 15,000 ESPP shares funded 5/15/09.
[F3]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F4]No expiration date.
[F5]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 133,334.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001414579

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 8:56 PM ET
Size: 8.4 KB

View on SEC.gov